Figure 4.
A basic therapeutic algorithm for thalassemia patients on regular blood transfusions. DFO = deferoxamine; DFP: deferiprone; Hb = hemoglobin concentration; HFrEF = heart failure with reduced left ventricular ejection fraction; MRA = mineralocorticoid receptor antagonists; RAASi = renin-angiotensin-aldosterone system inhibitors.39